检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:崔向丽[1] 高颖昌[1] 徐春敏[1] 史卫忠[1] 赵志刚[1]
机构地区:[1]首都医科大学附属北京天坛医院药剂科,北京100050
出 处:《药品评价》2012年第23期38-41,44,共5页Drug Evaluation
摘 要:本文通过检索国内外报道药源性肾结石的文献,对引起肾结石的药物进行分类归纳,总结可以引起肾结石的药物种类及发生机制,以帮助临床医师了解具有潜在引起肾结石风险的药物,规避药源性肾结石的发生率。引起肾结石的药物多由于长期大量用药所致,最常见的原型药物包括氨苯蝶啶、磺胺嘧啶、蛋白酶抑制剂等,药物代谢产物形成含钙或含嘌呤的结石。To summarize the types of drugs that can cause urinary stones and its mechanisms inducing urinary stone,meanwhile help clinicians understand and avoid the risk of drug-induced renal stones,the literature on domestic and foreign reports of drug-induced renal stones were classified and summarized.Renal stones are often caused by the long-term and high-dose use of drugs.The most common prototype drugs include triamterene,sulfadiazine and protease inhibitors.Drug metabolites mainly form stones with calcium or purine.The understanding of the potential risk of renal stones caused by drugs can effectively prevent and reduce the incidence of drug induced renal stones.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3